Aberdeen Group
EBS icon

Aberdeen Group’s Emergent Biosolutions EBS Stock Holding History

Aberdeen Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-255,147
Closed -$26.4M – 964
2020
Q3 		$26.4M Sell
255,147
-152,942
-37% -$16.5M 0.07% 228
2020
Q2 		$32.3M Sell
408,089
-109,953
-21% -$8.19M 0.09% 205
2020
Q1 		$30M Sell
518,042
-20,875
-4% -$1.2M 0.1% 176
2019
Q4 		$29.1M Buy
538,917
+34,074
+7% +$1.85M 0.07% 250
2019
Q3 		$26.4M Sell
504,843
-205,408
-29% -$9.57M 0.07% 265
2019
Q2 		$34.3M Buy
710,251
+170,268
+32% +$8.16M 0.08% 249
2019
Q1 		$27.3M Sell
539,983
-247,043
-31% -$14.6M 0.06% 296
2018
Q4 		$46.1M Sell
787,026
-310,421
-28% -$20M 0.11% 159
2018
Q3 		$72.2M Sell
1,097,447
-337,882
-24% -$19.7M 0.13% 146
2018
Q2 		$72.5M Sell
1,435,329
-68,969
-5% -$3.59M 0.14% 143
2018
Q1 		$79.2M Sell
1,504,298
-259,199
-15% -$12.9M 0.16% 136
2017
Q4 		$82M Buy
1,763,497
+66,909
+4% +$2.82M 0.16% 127
2017
Q3 		$68.6M Buy
+1,696,588
New +$61.4M 0.13% 155

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Aberdeen Group's EBS Position: Q4 2020 in Review

Aberdeen Group sold out of Emergent Biosolutions (EBS) in Q4 2020, closing a stake of 255,147 shares — an estimated $26.4M sold.

Aberdeen Group first reported a position in EBS in Q3 2017 and held it in 13 quarters. The position peaked at $82M in Q4 2017. 353 funds tracked by Wall St. Rank hold EBS as of Q4 2020.

  • Aberdeen Group reported no remaining Emergent Biosolutions position as of Q4 2020 after selling out during the quarter.
  • Aberdeen Group sold 255,147 Emergent Biosolutions shares in Q4 2020, an estimated $26.4M.
  • Aberdeen Group first reported a position in Emergent Biosolutions in Q3 2017 and held it in 13 quarters.
  • Aberdeen Group's Emergent Biosolutions position peaked at $82M in Q4 2017.
  • 353 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2020.

Based on Aberdeen Group's 13F filing for Q4 2020, filed 10 Feb 2021.